Accessibility Menu
Agilent Technologies logo

Agilent Technologies

(NYSE) A

Current Price$131.33
Market Cap$37.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)+417%
5 Year-9%
1 Year+14%
1 Month+6%
Agilent Technologies last closing stock price
MetricPriceDate
Last closeUSD 131.462026-07-17
Agilent Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.11%USD 134.292026-07-10
1 month+5.94%USD 124.092026-06-17
3 month+8.08%USD 121.642026-04-17
Year to date-2.81%USD 135.262025-12-31
1 year+13.88%USD 115.432025-07-17
3 year+12.49%USD 116.862023-07-18
5 year-8.54%USD 143.742021-07-16
Since inception+416.79%USD 25.441999-11-18

Agilent Technologies Financials at a Glance

Market Cap

$37.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$7.23B

Net Income (TTM)

$1.41B

EPS (TTM)

$4.98

P/E Ratio

26.40

Dividend

$1.01

Beta (Volatility)

1.02 (Average)

Price

$131.33

Volume

110,091

Open

$133.67

Previous Close

$131.33

Daily Range

$130.98 - $135.74

52-Week Range

$108.35 - $160.27

Estimated Earnings Date

Aug 26, 2026

A News

Two people in white lab coats looking at a computer display

Why Agilent Technologies Stock Triumphed on Thursday

Eric VolkmanMay 28, 2026
DNA with a section separated from the main part.

Best CRISPR Gene Editing ETFs for 2026 and How to Invest

Keith SpeightsMay 11, 2026
Foolcom-Featured.png

Agilent Reports 10% Revenue Jump in Q3

Motley Fool Markets TeamAug 27, 2025
featured-earnings-leadership-highlights.png

Agilent Raises Outlook on Q3 Growth

Motley Fool Markets TeamAug 27, 2025
Scientists in a lab

Why Agilent Technologies Stock Is Sinking Today

Keith SpeightsMay 24, 2023
Calendar cash pen

High-Profile Investor Bill Ackman Liquidates Coronavirus Hedges, Invests $2 Billion-Plus in Bargain Stocks

Anders BylundMar 25, 2020
GettyImages-1136590978

3 Stocks This Top Wall Street Pro Is Buying Right Now

Lee SamahaNov 13, 2019
192 biotech lab

Agilent Keeps Analysts Guessing, Beats Estimates in Q3

Maxx ChatskoAug 16, 2019
Page 1

A: Motley Fool Moneyball Superscore

73

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Agilent Technologies

Agilent makes tools that help scientists test medicine and chemicals. These products help doctors find diseases and keep food safe. The company serves researchers and lab experts all over the world.

Tools for Every Lab

  • Life Sciences and Diagnostics: Instruments and reagents (substances for chemical testing) used to study cells and DNA to identify diseases.
  • Agilent CrossLab: Service and repair plans for lab equipment and consumable supplies like filters that labs use daily.
  • Applied Markets: Specialized tools used to test chemical purity in food, water, and energy production.
  • Advanced Therapeutics: Manufacturing services for synthetic DNA components used as ingredients in new biotechnology drugs.

Acquisitions and Efficiency

  • Entered a definitive agreement on March 6, 2026, to acquire Biocare (BC Midco I, Inc.) for approximately $950 million.
  • Included Biocare within the Life Sciences and Diagnostics Markets segment to expand clinical and research capabilities.
  • Implemented the FY25 Plan in 2025 to optimize management structures and reduce workforce costs across all business segments.
  • Authorized a $2 billion share repurchase program in 2024 to manage stock dilution from employee equity plans.

A Neutral Global Partner

Agilent provides maintenance and compliance services for laboratory equipment regardless of which company manufactured the hardware. The company maintains a global presence with significant operations across the Americas, Europe, and the Asia Pacific region.

The Recent Performance

  • Total net revenue reached $1.84 billion for the quarter ended April 30, 2026, up 10% year-over-year.
  • Net income grew to $339 million in the second quarter of 2026, representing a 57.7% increase from 2025.
  • Free cash flow hit $370 million for the quarter ended April 30, 2026, up 245.8% from the previous year.
  • Cash and cash equivalents totaled $1.81 billion as of April 30, 2026.

Bottom Line

Agilent has shifted its focus from selling individual machines to providing full services and recurring supplies for laboratories. This approach creates a more stable business model by supporting customers throughout the entire life of their equipment.

AI Generated • Jun 2, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

18,100

CEO

Padraig Mcdonnell

Website

www.agilent.com

Headquarters

Santa Clara, CA 95051, US

A Financials

Key Financial Metrics (TTM)

Gross Margin

53.00%

Operating Margin

21.50%

Net Income Margin

19.55%

Return on Equity

20.84%

Return on Capital

14.65%

Return on Assets

10.82%

Earnings Yield

3.79%

Dividend Yield

0.77%

Payout Ratio

20.16%

Stock Overview

Market Cap

$37.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

282.43M

Volume

110.09K

Avg. Volume

2.37M

Financials (TTM)

Gross Profit

$3.83B

Operating Income

$1.56B

EBITDA

$1.96B

Operating Cash Flow

$1.45B

Capital Expenditure

-$196.00M

Free Cash Flow

$1.26B

Cash & ST Invst.

$1.81B

Total Debt

$3.36B

Agilent Technologies Performance Analysis

Agilent Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-10-31USD 6,848,000,0008.4%
20232023-10-31USD 6,833,000,000-0.2%
20242024-10-31USD 6,510,000,000-4.7%
20252025-10-31USD 6,948,000,0006.7%
Agilent Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-314.2%
Q42025-10-317.1%
Q12026-01-31-3.4%
Q22026-04-302.1%
Agilent Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-10-31USD 4.186.1%
20232023-10-31USD 4.190.2%
20242024-10-31USD 4.435.7%
20252025-10-31USD 4.573.2%
Agilent Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-07-3157.3%
Q42025-10-3129.7%
Q12026-01-31-30.1%
Q22026-04-3012.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.84B

+10.0%

Gross Profit

$1.01B

+16.5%

Gross Margin

54.99%

N/A

Market Cap

$37.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.05M

N/A

Employees

18,100

N/A

Net Income

$339.00M

+57.7%

EBITDA

$500.00M

+38.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.81B

+21.6%

Total Debt

$3.36B

-4.0%

Accounts Receivable

$1.50B

+9.7%

Inventory

$1.09B

+9.9%

Long Term Debt

$3.05B

-8.9%

Short Term Debt

$304.00M

+108.2%

Return on Assets

10.82%

N/A

Return on Invested Capital

14.40%

N/A

Free Cash Flow

$370.00M

+245.8%

Operating Cash Flow

$277.00M

+25.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IQVIQVIA Holdings Inc.
$206.26-2.01%
ALCAlcon Inc.
$70.26-0.51%
HLNHaleon plc
$10.10-0.10%
RMDResMed Inc.
$198.99-1.86%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
AALAmerican Airlines Group
$14.98-0.04%
NOKNokia
$10.12-0.03%
PATHUiPath
$12.15+0.01%

Questions About A

What is the current price of Agilent Technologies?

Agilent Technologies is trading at $131.33 per share.

What is the 52-week range for Agilent Technologies?

Over the past 52 weeks, Agilent Technologies has traded between $108.35 and $160.27.

How much debt does Agilent Technologies have?

As of the most recent reporting period, Agilent Technologies reported total debt of $3.36B.

How much cash does Agilent Technologies have on hand?

Agilent Technologies reported $1.81B in cash and cash equivalents in its most recent financial results.

What is Agilent Technologies’s dividend yield?

Agilent Technologies currently has a dividend yield of 0.77%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services